Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Wants Mobile App Guidance To Connect With Device-Reg-Naïve Developers

This article was originally published in The Gray Sheet

Executive Summary

Pending FDA guidance on mobile medical applications will be of most value in reaching out to those software developers who have not yet worked within the medical device industry, CDRH policy advisor Bakul Patel emphasized last week.
Advertisement

Related Content

FDA Mobile Health Policy Proposal Draws Fire From Far And Wide
FDA Mobile Health Policy Proposal Draws Fire From Far And Wide
FDA Mobile Health Policy Proposal Draws Fire From Far And Wide
FDA Urged To Create mHealth Regulatory Office
FDA Urged To Create mHealth Regulatory Office
FDA Outlines Path For Guidance On Clinical Decision Support Tools
Industry Applauds FDA Draft Guidance On Mobile Medical Apps
Industry Applauds FDA Draft Guidance On Mobile Medical Apps

Topics

Advertisement
UsernamePublicRestriction

Register

MT030544

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel